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We have investigated the interactions between two carrier peptides and model membrane systems as well as the conformational consequences of
these interactions. Studies performed with lipid monolayers at the air–water interface have enabled identification of the nature of the lipid–peptide
interactions and characterization of the influence of phospholipids on the ability of these peptides to penetrate into lipidic media. Penetration
experiments reveal that both peptides interact strongly with phospholipids. Conformational investigations indicate that the lipid–peptide interaction
govern the conformational state of the peptides. Based on the ability of both peptides to promote ion permeabilization of both natural and artificial
membranes, we propose a model illustrating the translocation process. For MPG, it is based on the formation of a h-barrel pore-like structure, while
for Pep-1, it is based on association of helices.
D 2005 Elsevier B.V. All rights reserved.Keywords: Cell-penatrating peptide; Amphipatic peptide; Interactions with membrane; Conformation; Spectroscopic analysis
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assembly of hydrophobic and hydrophilic domains. The first one
is required for membrane anchoring and for complex formation
with hydrophobic cargoes. The hydrophilic domain is required
to address a subcellular compartment, to improve the solubility
of the vector and for complex formation with hydrophilic
negatively-charged molecules [1].
There are three major families of primary amphipathic
peptides: those derived from a signal peptide (SP) [2,3], from a
fusion peptide (FP) as found in the MPG family [3,4], and the
tryptophan-rich sequences forming the Pep family [5]. These
three families have a common hydrophilic domain, the Nuclear
Localization Sequence (NLS) of SV40 large T antigen:
PKKKRKV [6]. All these peptides bear a WSQ sequence which
acts as a linker between the hydrophilic and hydrophobic
domains, thereby maintaining their integrity. The selected SP
sequence corresponds to that of the light chain of the immuno-
globulin of caiman crocodylus while the FP of MPGwas chosen
from HIV-1 fusion protein gp41. For Pep peptides, the
hydrophobic sequence was selected from the dimerization motif
at the interface of HIV-1 reverse transcriptase. All of these
peptides are acetylated and bear a cysteamide group at their N-
and C-termini, respectively.
GALFLGFLGAAGSTMGAWSQPKKKRKV for MPG
KETWWETWWTEWSQPKKKRKV for Pep-1
The peptides of the SP family enter cells very rapidly at 4 -C
as well as at room temperature. Since endocytosis inhibitors
have no effect on cell entry, the endocytosis pathway has been
ruled out to explain the mechanism of internalization. These
peptides have been used for the intracellular delivery of
oligonucleotides [3] or porphyrin [7] derivatives which are
covalently linked to the carrier though the cysteamide moiety.
However, they have proved to be toxic when used at
concentrations higher than 10 AM due to pore formation which
generates membrane depolarization [8].
Attempts to overcome this property were made by designing
the MPG family based on the association of a fusion sequence to
the above-mentioned NLS and linker. Several variants of the
parental peptide have been tested. The first one (MPG-W) is the
result of a W7 to F substitution and results in efficient nuclear
localization in fibroblasts [1,3,9]. This behavior prompted us to
synthesize other variants in order to control the addressed
subcellular compartment for nucleic acid cargoes. This was
achieved by a K to S substitution in position 23 corresponding
to the second lysine of the NLS sequence, generating the
vector peptide MPG-DNLS. This substitution was made to
reduce nuclear addressing by decreasing the number of
positive charges, and thereby also reducing the stability of
the complex formed with the negatively charged nucleic
acids. MPG-DNLS was shown to efficiently transfer single-
and double-stranded oligonucleotides, RNAs [4,10], siRNAs
[11,12], double-stranded phosphorothioate oligonucleotides
[13] and more sophisticated oligonucleotides such as N3VYP5V
thio-phosphoramidates without formation of any covalent
linkage [14,15].The peptides of the Pep family differ from MPG in the
nature of the hydrophobic sequence and were designed with the
aim of delivering peptides, proteins or PNAs [5,16]. Pep-1, the
leader peptide of the Pep family, forms complexes with proteic
cargoes which are rapidly delivered into a great variety of cell
lines and applied in cellulo and in vivo [17,18].
1. Mechanisms of translocation
Identification of the mode of action of CPPs is crucial for the
design of future generations of CPPs. Investigation of the
mechanism of internalization requires identification of several
physicochemical properties of the carrier peptides. First, it is
crucial to elucidate the type of interaction that they can elicit in
the presence of membrane components, mainly the phospholi-
pids. It is also necessary to identify the structural criteria, mainly
the peptide primary and secondary structures, which can
influence the internalization process. Finally, three main entry
mechanisms can be examined: direct penetration into the
membrane, translocation through formation of a transient
structure and an endocytosis-mediated entry.
With respect to the interactions of CPPs with the plasma
membrane, most data stress the role of positive charges, which
allow direct electrostatic interactions with phospholipid head-
groups. However, some differences can be noticed depending on
the nature of the CPP. As an example, penetratin differs from
transportan in that the former interacts preferentially with
negatively charged membranes whereas interactions of the latter
do not depend on charges [19]. Furthermore, comparison of
internalization properties of all-L with those of all-D peptides
[20,21] indicate that this process is not receptor-mediated as
confirmed by the use of giant unilamellar vesicles [22]. Other
investigations point out the importance of the heparan sulfates
(HS) present at the cell surface. Indeed, internalization of Tat,
penetratin and polyarginines is inhibited upon degradation of the
heparan sulfates, by addition of heparin or sulfated polysacchar-
ides or HS deficient cell lines [23–25]. However, other authors
claim that Tat and penetratin can enter cells independently of the
presence of heparan sulfates [22,26].
A last mechanism has recently been proposed for internal-
ization mediated by peptides belonging to the family of primary
amphipathic peptides, namely MPG and Pep-1. On the basis of
physico-chemical investigations, including CD, FTIR, and
NMR spectrometry [27–30] associated with electrophysiolog-
ical measurements and investigations dealing with the use of
systems mimicking model membranes such as monolayers at the
air–water interface and transferredmonolayers, two very similar
models have been proposed. Both are based on the formation of
transient pore-like structures. The main difference between the
model proposed forMPG and that proposed for Pep-1 is found in
the structure giving rise to the pore structure. For MPG, it is
formed by a h-barrel structure [29], while that of Pep-1 depends
on association of helices [30]. For both peptides, strong
hydrophobic phospholipid–peptide interactions have been
detected and in both models the folded parts of the carrier
molecule correspond to the hydrophobic domain while the rest
of the molecule (linker+NLS) remains unstructured.
Fig. 1. Far UV CD spectra of transferred Pep-1 containing monolayers. Pure
peptide (spectrum 1) and peptide in the presence of DOPC or DOPG at a
peptide/lipid ratio of 0.25 (spectra 2 and 3, respectively).
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which were used and enabled us to the proposal of pore-based
models accounting for the cellular internalization process of
MPG and Pep-1.
2. Conformational investigations and physicochemical
approaches
2.1. Pep-1
2.1.1. Structural characterization of Pep-1 in solution and in
the presence of a SDS
For concentrations ranging between 0.1 and 0.3 mg/mL, the
CD spectrum of Pep-1 in solution in water shows a single
negative band centered at 202 nm associated with a shoulder
around 220 nm, suggestive of a non-structured or poorly ordered
structure. Interestingly, increasing the concentration of Pep-1 up
to 3 mg/mL promotes a dramatic modification which leads to a
spectrum characterized by a minimum at 205 nm, a pronounced
shoulder at 221 nm, and a maximum at 190 nm, representative of
a helical conformation [30]. This tendency for Pep-1 to adopt, at
least in part, a helical structure is confirmed by observations in
SDS-containing media. Indeed, above the CMC of the detergent,
a spectrum with two minima at 207 and 222 nm and a maximum
at 192 nm is obtained, characterizing a helical conformation [31].
The helical folding of Pep-1 is confirmed by NMR investiga-
tions. The sequential andmedium range NOEs observed for Pep-
1 in H2O and Pep-1 in the presence of SDS. The observed NOEs
for Pep-1 in H2O in the segment 4–13 are consistent with the
existence of a helical secondary structure in this part of the
sequence. In the presence of SDS, the observed NOEs are
characteristic of a helix for the same segment (residues 4 to 13).
In addition, several NOEs detected at the beginning of the
sequence are indicative of a 310 helix. The extension of the helical
structure to the N-terminus of Pep-1 in medium containing SDS
is the only difference observed between the conformation of Pep-
1 in H2O and Pep-1 in SDS micelles. Interestingly, the NLS
moiety of Pep-1 remained unstructured in both media [30].
2.1.2. Structural characterization of Pep-1 in the presence of
phospholipids
Wehave also characterized the structural states of Pep-1 in the
presence of phospholipids. As shown by CD, successive
addition of vesicles of DOPC/DOPG 80/20 to a dilute solution
of Pep-1 in water induced a structural transition. Owing to the
existence of isodichroic points around 220 nm, the conforma-
tional transition is the result of a transition between two states.
The first state corresponds to a non-structured form, while the
second is more difficult to identify unambiguously due to the
presence of 5 Trp residues which are most likely involved in the
contribution at 228 nm. Nevertheless, since the spectra always
show a maximum at about 191 nm and a minimum located in the
206–208 nm range, with no minimum between 215 and 220 nm,
the presence of a h-sheet structure can be ruled out, and these
data therefore also suggest that the conformation of Pep-1 is
helical in the presence of phospholipids. The helical structure
adopted by Pep-1 in the presence of phospholipids is confirmedby CD observations performed on peptide-containing trans-
ferred monolayers (Fig. 1) [32]. In all cases, with or without any
type of lipid, whether neutral or negatively charged, the spectra
exhibit two minima at 206 and 222 nm and one maximum
around 190 nm, indicating that a helical structure is the major
structural component. From the FTIR point of view, all spectra
showed a complex contour of the Amide I band. In the absence
of lipids and at low lipid/peptide ratio (DOPC), two distinct
contributions were observed, one at 1625–1630 cm1 and the
other centered at 1655–1660 cm1. An increase of the DOPC/
peptide ratio generated a significant decrease of the 1625 cm1
contribution associated with a broadening of the 1655–1660
cm1 contribution [33]. The same behavior was obtained with
DOPG instead of DOPC (data not shown). The finding of a
broad band is in full agreement with the NMR data obtained in
SDS (see above) and indicates that two helical forms are
maintained in a lipidic medium. (1655 cm1, a-helix; 1665
cm1, helix 310) [34,35].
2.1.3. Studies at the air–water interface—adsorption at
lipid-containing interfaces
The ability of Pep-1 to penetrate into lipidic media was
determined by the monolayer approach. This requires first the
determination of the saturating surface pressure induced by the
peptide at a lipid-free air–water (0.154 M NaCl) interface. The
variation of the surface tension as a function of the peptide in
the subphase shows that saturation is obtained at a concentra-
tion of 5107 M Pep-1 and that the corresponding surface
tension is rather low (4 mN/m) compared to other cell-
penetrating peptides studied previously in our laboratory
(>15 mN/m) [2,36]. Such a low increase of the surface tension
indicates that Pep-1 has a weak amphipathic character. The
understanding of the mechanism through which Pep-1 pene-
trates into membranes was performed through penetration
experiments using phospholipids in the liquid expanded
(DOPC and DOPG) or liquid condensed (DPPC and DPPG)
states. In the case of liquid-expanded monolayers, a strong
increase in the surface pressure is observed. The most
important characteristics of these experiments lie in the fact
that (i) both DOPC and DOPG yielded identical cpi (45 mN/m)
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and 32 mN/m for DOPC and DOPG, respectively), and
significantly different from that measured in the absence of
lipid (Fig. 2). For the two other phospholipids, DPPC and
DPPG, again the cpi is high (33 mN/m) and does not depend
on the nature of the headgroups. The high values found for the
cpi suggest that the Pep-1 can spontaneously insert into natural
membranes [37]. Extrapolations at zero initial pressure provide
a good indication that strong peptide–lipid interactions can
occur at least in monolayers, with all lipids except DPPC.
2.1.4. Penetration into phospholipid vesicles
The ability of Pep-1 to penetrate into phospholipid bilayers
was investigated by fluorescence spectroscopy. The peptide
contains five Trp residues in its hydrophobic moiety, which
represent sensitive probes for monitoring interactions and
changes in its environment upon penetration into phospholipid
bilayers by intrinsic fluorescence. Successive additions of
phospholipid vesicles to a solution of Pep-1 induce significant
changes in the fluorescence spectrum. Indeed, a continuous shift
of the fluorescence maximum (from 350 to 328 nm) accompa-
nied by quenching of fluorescence occurs when the lipid/peptide
ratio increases from 0 to 5. The blue shift of fluorescence is
consistent with a change in the environment of the Trp residues
from polar to nonpolar in the presence of phospholipid vesicles
[38]. This is a good indication that the Trp residues are
embedded in the lipidic core when Pep-1 encounters a
membrane. In addition, quenching is suggestive of a transfer
between Trp residues which are engaged in clusters when the
peptide adopts a helical structure.
2.1.5. Formation of carrier/cargo complexes and structural
consequences
Finally, the study of the ability of Pep-1 to interact with P-A, a
32-mer cargo peptide was investigated by intrinsic tryptophan
fluorescence spectroscopy together with the structural conse-
quences of this interaction. Binding of P-A peptide to Pep-1
induced a marked quenching of the intrinsic tryptophanFig. 2. Variation of the surface pressure as a function of the initial surface
pressure of the phospholipid monolayer for Pep-1. (D) DOPC, (o) DOPG, (m)
DPPG, and (a) DPPC. Extrapolation at zero initial pressure gives the critical
pressure of insertion.fluorescence of Pep-1, with a saturating value of 36%.Moreover,
the blue shift of the fluorescence emission maximum of 11 nm,
(from 350 to 339 nm, data not shown), suggests that the Trp
residues of Pep-1 interact directly with the cargo peptide P-A.
Saturation is reached at a concentration of 200 nM, that is, 5-fold
lower than that of the Pep-1 (1 AM), suggesting that the cargo
peptide interacts with more than one molecule of Pep-1 peptide
vector. The interaction between Pep-1 and P-A remains stable at
high salt concentrations (300 mM NaCl), revealing that binding
to Pep-1 mainly involves hydrophobic contacts. Taking into
account the number of Pep-1 molecules bound to the cargo
peptide P-A, the dissociation constant was estimated to be in the
range of 120–150 nM, indicating that when Pep-1 is mixed with
a peptide in solution they associate rapidly into noncovalent
stable complexes through hydrophobic interactions. This exper-
iment was repeated using P-B whose sequence strongly differs
from that of P-A and led to the same conclusion. This indicates
that the binding is not specific for a given peptide. As to the
conformational consequences of these interactions, CD observa-
tions indicate that the formation of a complex does induce any
structural modification of Pep-1. Finally, to complete our
understanding of the relationship among the interactive ability
of Pep-1 with its cargo, its penetrating capacity, and its
conformational state, we examined whether the presence of
phospholipids induced any structural modifications on Pep-1
complexed to its cargo, similar to those already detected for Pep-
1 in its free form. Upon addition of vesicles made of DOPC/
DOPG (80/20) to a preformed Pep-1/P-A complex, the mod-
ifications of the CD spectrum show the same trend as those
obtained for free Pep-1 to which lipid vesicles were added. This
result indicates that the particle formed by complexes of Pep-1
and its cargo interacts with lipid bilayers and that this interaction
promotes, at least in part, a conformational transition of Pep-1 to
an a-helical form.
P-A=RGTKALTEVIPLTEEAELELAENREILKEPVH and
P-B=MEFSLKDQEAKVSRSGLYRSPSMPENLNRPRLKQ-
VEKFKDNTIPDKKKC.
2.1.6. Electrophysiological measurements
When Pep-1 (10 AM) is applied to voltage-clamped oocytes, a
marked increase in membrane conductance is noted. This
increase is best visualized by an increase in membrane current
recorded during voltage ramps applied from 80 mV (the usual
holding potential) to +80 mV (see Fig. 3). Taken together, these
results suggest that the permeabilizing capabilities of Pep1 are
due to the formation of membrane ion channels.
2.2. MPG
2.2.1. CD investigations
When in solution in water, peptide MPG exhibits a CD
spectrum with a single minimum at 198 nm, characteristic of a
nonordered structure. The spectrum remains unchanged either
when the concentration of peptide is varied or when phosphate
buffer is added. For spectra obtained on transferred monolayers
made of pure peptides, the spectrum of peptide MPG strongly
differs from that obtained when in solution in water. It is now
Fig. 4. Variation of the surface pressure as a function of the initial surface
pressure of the phospholipid monolayer for MPG. (D) DOPC, (o) DOPG, (m
DPPG, and (a) DPPC. Extrapolation at zero initial pressure gives the critica
pressure of insertion.
Fig. 3. Macroscopic current-voltage curve measured during application of Pep-
1 or MPG peptide using a voltage-ramp from 80 to +80 mV. The current is
displayed after digital subtraction of current recorded before peptide
application. Trace a corresponds to the current induced by Pep-1 while trace
b was obtained using MPG.
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associated with a maximum at 191 nm. Such a spectrum is
characteristic of a sheet structure.
2.2.2. FTIR investigations in the presence of phospholipids
The influence of phospholipids on the conformation of the
peptides was examined by FTIR. These experiments were
carried out using the same procedure as reported previously
[39]. For peptide MPG, the FTIR spectra show that in the
absence and in the presence of phospholipids (DOPC, DOPG,
DPPC, and DPPG) at any peptide/lipid ratio, above 0.05, the
sheet structure, as characterized by the presence of a major
amide I band component centered around 1625 cm1 is
favored. The existence of a broad contribution around 1650
cm1 suggests the presence of unfolded domains as already
observed by NMR studies of similar peptides engaged in
micelles of SDS where the C-terminal NLS sequence always
remains unfolded [2,9]. It must be noted that neither the nature
of the lipid nor the peptide/lipid ratio modify the conforma-
tional state of peptide MPG as reported previously for a peptide
containing the same hydrophobic sequence but with slight
extensions at the C- and N-termini.
2.2.3. Studies at the air–water interface—adsorption at
lipid-containing interfaces
The ability of peptide MPG to insert into phospholipid
monolayers spread at the air–water interface was monitored
by measuring variations in surface tension using different
initial pressures and by injecting a given peptide concentra-
tion in the subphase. The selected concentration is slightly
less than the equilibrium spreading pressure of the peptide
[40]. Various penetration experiments were carried out using
four different phospholipids where the nature of the head-
groups (zwitterionic or negatively charged) and the physical
state (liquid expanded or liquid condensed) were varied. The
various plots of pressure variation versus the initial surface
pressure are reported in Fig. 4. In the case of peptide MPG,
although still high, the critical pressure of insertion increasesfrom 30 to 38 mN/m for DPPC and DPPG, respectively,
indicating a better uptake by negatively charged phospholi-
pids (Fig. 4). For lipids in the liquid expanded (LE) state,
insertion depends on both the initial conformational state of
the peptide and the nature of the headgroups. In all cases, the
critical pressures of insertion are high (see Fig. 4). Further
examination of Fig. 4 also provides information on the
interactions occurring between the peptide and the phospho-
lipids considered here. These are based on the pressure value
measured for an air–water interface at low lipid content (i.e.,
at low initial pressure). The finding of surface pressures
higher than these obtained for the pure peptides at saturation
is indicative of strong peptide–lipid interactions [41]. This is
the case of MPG particularly in the presence of negatively
charged phospholipids.
2.2.4. Conformational investigations in the presence of
phospholipids
In water, the CD spectrum of MPG exhibits a single
minimum centered at 198 nm, which is typical of that
expected for a non-structured peptide [42]. Upon addition of
phospholipid vesicles made of DOPG or DOPC/DOPG
(80:20), drastic changes in the CD spectrum are observed.
These modifications are characterized by a strong decrease in
the intensity of the negative band at 198 nm associated with a
slight increase in the contribution centered at 223 nm. To
identify the nature of the lipid-induced conformation, com-
parison with the structural behavior of MPG was carried out
in the presence of SDS. Addition of SDS generates two
different processes depending on the concentration of SDS in
the medium. The first process occurs at low SDS concentra-
tions (below 2.2103 M) and can be interpreted as a
random coil–h sheet transition. Indeed, the spectrum of MPG
obtained in pure water is typical of that of a non-structured
peptide, while that at 2.2103 M SDS suggests that the
peptide adopts, at least in part, a sheet structure. As to the
second process, which occurs at higher SDS concentrations,
i.e., around the critical micellar concentration, it can be)
l
Fig. 5. Variation of the relative fluorescence intensity (maximum of the
emission spectrum) of HEX-labeled bcl-2 oligonucleotide (solution containing
10 nmol) as a function of the concentration of MPG peptide.
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form to a form which is, at least in part, helical (one
maximum around 192 nm and two minima at 206 and 222
nm), the NLS remaining unstructured. Therefore, due to the
strong similarity to the spectra detected at low concentration
of SDS, the lipid-induced conformational change can be
assigned to a conformational transition with formation of a
sheet structure, at least in part, and rules out the existence of
any helical structure. The existence of a sheet structure as the
major structural component is confirmed by FTIR observa-
tions which reveal, in the presence of phospholipids, the
existence of a major Amide I band around 1625 cm1
associated with a broad shoulder at 1655 cm1 [43]. On theFig. 6. Model for the translocation process of Pep-1/cargo and MPG/cargo complexe
(1) formation of the complex, (2) membrane uptake of the complex, (3) transloc
convention: red corresponds to the NLS of both carrier, yellow and orange to the hbasis of NMR data obtained in solution in water, with and
without micelles of SDS [36], it can be stated that the
hydrophobic sequence of the peptide corresponds to the
folded domain while the remainder corresponding to the NLS
is not structured.
2.3. Polynucleotide binding and induced conformational
changes
2.3.1. Polynucleotide binding
Fluorescence and gel shift assays were used to monitor
formation of a peptide/oligonucleotide complex. A solution of
HEX-labeled oligonucleotide (18-mer) was titrated with MPG.
Changes in fluorescence intensity were monitored and are
reported in Fig. 5, showing an abrupt linear decrease the
extrapolation of which reveals a ratio of about 7 peptides per
oligonucleotide. In terms of charges, this result indicates that
the positive/negative charge ratio is 2 for the complex in good
agreement with previous results obtained with a double-
stranded DNA [44]. An identical stoichiometry for the complex
was obtained by titration of the peptide by the oligonucleotide.
Moreover, determination of the equilibrium constants from
both experiments indicates that the peptide exhibits high
affinity for the oligonucleotide, respectively, 6 and 5 nM.
In gel shift assays, oligonucleotide was incubated with the
peptide at different peptide/oligonucleotide ratios and then
submitted to gel migration. For a charge ratio (+/) of 1 or
lower, the band corresponding to the free form of the
oligonucleotide can be detected, while an increase of this ratio
leads to disappearance of this band, accompanied by an
increase in the amount of precipitated material remaining in
the injection well. Taken together, these data indicate that thes through phospholipid bilayers. For both carriers, the four steps correspond to
ation through the bilayer, and (4) release into the cytoplasmic side. (colour
ydrophobic domain of MPG and Pep-1, respectively).
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cargo to form a complex containing most probably more than 7
peptide molecules per oligonucleotide.
2.3.2. Induced conformational changes
Addition of the oligonucleotide to a solution of MPG in
water in an oligonucleotide/peptide ratio ranging from 0 to 0.05
promotes changes in the CD spectrum. These spectral varia-
tions indicate a decrease in the amount of unfolded peptide to
the benefit of sheet structures. Interestingly, the CD spectra
obtained for oligonucleotide/peptide ratios ranging from 0 to
0.1 indicate formation of a small but significant amount of h-
sheet structure. The mixtures corresponding to the ratios
previously used in transfection assays (0.1 or 0.2) [4,10,
12,45] were used for further experiments related to the
influence of phospholipids on the structure of the peptide
engaged in a complex with oligonucleotide. Typical observed
variations of the CD spectrum reveal that addition of DOPG
induces spectral modifications that are similar to those
observed in the absence of oligonucleotide, thereby indicative
of formation of a h-sheet-based structure.
2.3.3. Peptide-induced ionic leakage
When the peptide (30 AL of a 10-AM peptide solution) in its
free form or engaged in a complex at an oligonucleotide/
peptide ratio of 0.1 was applied to voltage-clamped oocytes,
marked increases in membrane conductance were observed
(Fig. 3). The presence of nucleic acids has no effect on the
reversal potential (12 mV) but appears to reduce the current
amplitude. We cannot decide now whether this decrease in the
current arises from an artificial decrease of the peptide
concentration because it is engaged in the complex, or to
modification of the transmembrane current characteristics.
Nevertheless, electrophysiological measurements strongly re-
semble those obtained for Pep-1 and for other channel-forming
cell-penetrating peptides [8,30], suggesting thus, that the
peptide-induced membrane permeabilization properties are
due to formation of an ion channel.
3. The models
On the basis of physicochemical investigations, including
CD, FTIR, and NMR spectrometry associated with electro-
physiological measurements and investigations dealing with
the use of systems mimicking model membranes such as
monolayers at the air–water interface and transferred mono-
layers, two very similar models have been proposed. Both are
based on the formation of transient pore-like structures. The
main difference between the model proposed for MPG and that
proposed for Pep-1 is found in the structure giving rise to the
pore structure. For MPG, it is formed by a h-barrel structure
(Fig. 6), while that of Pep-1 depends on association of helices
(Fig. 6). Such a model accounts with the expected length of the
helical transmembrane domain of Pep-1. In the case of MPG,
the situation is less clear. Indeed, a sheet structure with 17
residues is much longer than the thickness of a bilayer (about a
2-fold). Therefore, in that case, the possibility of a hairpin-likestructure favoring an antiparallel arrangement, as suggested by
the infrared observations, cannot be rule out.
4. Conclusions and perspectives
Although, some of the cell-penetrating peptides described
above begin to receive applications mainly in research
laboratories, some weaknesses are still encountered, in
particular due to the lack of specificity toward targets. This
implies that some modifications of their sequences or the
introduction of non-natural amino acids bearing side-chains
that can improve their specificity is required. However, it is
now known that modifications in their sequences, although
minor, can strongly modify their ability to act as drug carrier.
It is therefore necessary to identify precisely the criteria
which can define an efficient cell-penetrating peptide with a
high degree of drug transfer. This requires the understanding
of the interactions of these carrier peptides with all the
membrane components in association with the structural
consequences of these interactions. These criteria have to be
satisfied and will help in the design of the next generation of
carrier peptides.
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